Preconception carrier screening may now be offered to specific high-risk populations, for instance based on ancestral background. However, when screening is expanded to multiple (mostly) autosomal and X-linked recessive disorders and offered to couples or individuals regardless of ancestry or geographic origin, ethical discussion is warranted. Do the possible benefits of such screening clearly outweigh the possible harms and disadvantages in the context of assisted reproduction, and, if so, for what kinds of disorders and under what conditions?
These and other questions raised by the wider application of ECS are addressed by the Committee’s latest guidance published in HROpen.
Read the guidance
Share this page
Technical aspects of preconception expanded carrier screening will be addressed in an ESHRE good practice recommendations paper (expected in 2022)